Internal Operational Strategies Drive Clinical Trial Start Times More Than Regulatory Review Periods

Clinical trial timelines vary significantly across the pharmaceutical industry despite uniform regulatory review periods, according to recent industry analysis. Research indicates that internal organizational structures, the use of dedicated trial units, and specific site operational strategies serve as the primary drivers for the speed at which companies enroll their first patients. These…